Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Andrographolide Inhibits Corneal Fibroblast to Myofibroblast Differentiation In Vitro

Biomolecules(2022)10.3390/biom12101447Source: DataRank Database

Andrographolide Inhibits Corneal Fibroblast to Myofibroblast Differentiation In Vitro is a research paper published in Biomolecules (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.63)OA: goldTopics (76)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Melinda Quan,Theint Aung ORCID,Jennifer Kang ORCID,Sara M. Thomasy ORCID,Brian C. Leonard ORCID

Live enrichment

PubMed:36291655 PMC:PMC9599903 OpenAlex:https://openalex.org/W4303946595

National Institutes of Health

Grant: K08EY02819

National Institutes of Health

Grant: R01EY016134

National Institutes of Health

Grant: P30EY12576

NEI NIH HHS

Grant: K08 EY028199

NEI NIH HHS

Grant: P30 EY012576

National Institutes of Health

Grant: 5P30EY012576-18

Vision Research Core Grant

National Institutes of Health

Grant: 5R01EY016134-08

Modulation of Signal Transduction by Nano-Topography

National Institutes of Health

Grant: 1K08DK002819-01A1

HEMODIALYSIS AND OXIDATIVE STRESS

FWCI

0.63

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2218-273X/12/10/1447/pdf?version=1666688283

publisherhttps://www.mdpi.com/2218-273X/12/10/1447/pdf?version=1666688283

publisherhttps://www.mdpi.com/2218-273X/12/10/1447/pdf

journalhttps://doi.org/10.3390/biom12101447

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36291655

Fields of Study

Testicular diseases and treatmentsAndrographolide Research and ApplicationsNatural Compounds in Disease Treatment03 medical and health sciences0302 clinical medicineRabbitsRatsAnimalsTransforming Growth Factor beta1MyofibroblastsActinsCells, CulturedFibroblastsDiterpenesCorneaFibrosisRNA, Messenger

MeSH Terms

ActinsAnimalsCells, CulturedCorneaDiterpenesFibroblastsFibrosisRabbitsRNA, MessengerRatsTransforming Growth Factor beta1Myofibroblasts

Keywords

AndrographolideMyofibroblastFibrosisCorneaTransdifferentiationIn vivoMedicinePathologyCancer researchChemistryOphthalmologyPharmacologyIn vitroBiologyBiochemistryCorneal Wound HealingCorneal FibrosisPhysical Injury - Accidents and Adverse EffectsCellsMessengerMedical biotechnology610EyeMicrobiologyArticleTransforming Growth Factor beta16162.1 Biological and endogenous factorsAnimalsRNA, MessengerWound Healing and CareMyofibroblastsEye Disease and Disorders of VisionCells, CulturedOphthalmology and OptometryCulturedBiomedical and Clinical SciencesPreventionFibroblastsBioinformatics and computational biologyQR1-502ActinsRatsBiochemistry and cell biologyRNARabbitsDiterpenes

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being